News Related to: Patient Care
-
Columbia Neurology Ranked #2 in Nation in NIH Funding!
In 2017, the Department of Neurology was ranked #2 in NIH-funded research among medical school neurology...
-
US News and World Report Best Hospitals: 2018-2019
NewYork–Presbyterian Hospital is #5 in the nation and...
-
Welcome New Faculty!
New Clinicians and Basic Scientists Join Columbia Neurology
-
For Patients with Depression and Mild Cognitive Impairment, Popular Alzheimer’s Medication Is Not Effective
Results from a clinical trial conducted by Columbia University Irving Medical Center and Duke University Health System suggest that donepezil—an Alzheimer’s drug—may not improve cognitive...
-
PANDAS: When a Simple Strep Throat Leads to Frightening Behavior
"Your body is equipped with immune cells to fight infections and, in the case of strep [that leads to PANDAS], that immune system is fighting the strep infection then erroneously begins to attack...
-
ALS Community Workshop in Washington, D.C.
Columbia Neurology amyotrophic lateral sclerosis (ALS) specialist Dr. Jinsy Andrews recently participated in the ALS Community Workshop in Washington, D.C. to provide feedback to the Food and Drug...
-
Dr. Cigdem Akman Named Chief of Child Neurology at NewYork-Presbyterian Morgan Stanley Children’s Hospital
Dr. Cigdem Akman has been named chief of child neurology at NewYork-Presbyterian Morgan Stanley Children’s Hospital. An expert in child and adolescent epilepsy, Dr. Akman has served as director of...
-
Can a Smell Test Sniff Out Alzheimer’s Disease?
The sense of smell is one of the first things to change as Alzheimer’s disease takes root, even before other symptoms appear. That’s raised the idea that a scratch-and-sniff test that rates an...
-
Alzheimer Drugs Keep Failing, Can Big Data Help?
This week another pharmaceutical company announcedit had given up on developing an Alzheimer’s drug, and the news was not a surprise. It follows announcements just this past Mayand Februaryof...
-
More Epilepsy Cases Linked to the Mosaic Brain
Mutations that occur only in a subset of brain cells may account for a significant fraction of specific types of epilepsy, according to a new study led by researchers in the Institute for Genomic...
